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Inhibition of the chemokine receptor CXCR2 prevents kidney
graft function deterioration due to ischemia/reperfusion.
Background. Ischemia/reperfusion (I/R) injury after organ
transplantation is a major cause of delayed graft function. Fol-
lowing I/R, locally produced CXC chemokines attract and acti-
vate granulocytes, which in turn promote graft damage.
Methods. We examined the involvement of granulocyte re-
cruitment via the CXCR2 pathway in a rat model of 4 hours
cold ischemia followed by kidney transplantation. Serum crea-
tinine and intragraft granulocyte infiltration were monitored in
the early phase posttransplant. A CXCR2 inhibitor, repertaxin,
was given to recipients before transplantation (at −24 hours or
−8 hours or −2 hours), immediately before reperfusion and 2
hours later.
Results. An increase of granulocyte chemoattractant CINC-
1/interleukin-8 (IL-8) mRNA expression after I/R both in syn-
geneic and allogeneic transplantation was associated with a
marked infiltration of granulocytes in renal tissue. In syngeneic
transplantation, Lewis rats given 15 mg/kg repertaxin 24 hours
before surgery had granulocyte graft infiltration and serum cre-
atinine levels significantly reduced in respect to vehicle-treated
animals. Intermediate effects were observed with 5 mg/kg,
whereas the dose of 30 mg/kg had toxic effects. We found that
reducing the pretreatment time to 8 hours before surgery was
still effective. Prevention of granulocyte infiltration and serum
creatinine increase was also obtained in allogeneic transplan-
tation, when Brown Norway recipients of Lewis kidneys were
given 15 mg/kg repertaxin starting 8 hours before surgery.
Conclusion. Repertaxin treatment of the recipient animal
was effective in preventing granulocyte infiltration and renal
function impairment both in syngeneic and in allogeneic set-
tings. The possibility to modulate I/R injury in this rat model
opens new perspectives for preventing posttransplant delayed
graft function in humans.
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Ischemia/reperfusion (I/R) injury is an important cause
of organ failure in transplant medicine due to the re-
establishment of blood flow to ischemic tissues that causes
greater injury than that induced by ischemia secondary
to organ retrieval, storage, and surgery [1]. Impaired or
delayed graft function occurs in as many as 50% ca-
daveric kidney recipients [2] and requires supportive
measures, including prolongation of the length of the hos-
pital stay as well as of the dialysis period with consequent
amplification of the costs and difficulties in administra-
tion of immunosuppression. There is also evidence that
the incidence of acute rejection affecting the long-term
graft survival is higher in organs with delayed graft func-
tion than in those that function immediately [3, 4]. The
lack of effective treatments for preventing or curing the
occurrence of delayed graft function has prompted the
transplant community to focus on identifying drugs that
stabilize or reverse I/R injury. The mechanism(s) of in-
jury in I/R involves activation of endothelial cells which
are induced to express high levels of surface adhesion
molecules, including P- and E-selectin and produce cy-
tokines and chemokines capable to attract neutrophils
and macrophages promoting a nonspecific host inflam-
matory response [5]. Activated granulocytes release va-
soactive mediators in turn responsible for the decrease in
renal blood flow. Subsequent major histocompatability
complex (MHC) class II antigens up-regulation and en-
hanced T-cell recruitment instigate an antigen-dependent
alloimmune response.
Among the early proinflammatory chemokines,
interleukin-8 (IL-8), a member of CXC chemokines, in
which two NH2-terminal cysteines are separated by a sin-
gle nonconserved amino acid residue, is believed to play
a key role in I/R injury [6]. IL-8 has a major effect in
attracting neutrophils and T lymphocytes at the inflam-
mation site [7, 8]. Rodents lack a homologue of IL-8 but
possess other CXC chemokines acting through CXCR2,
namely CINC-1 (also called KC or Gro-1), MIP-2, and
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CINC-2, which share with IL-8 the properties of granu-
locyte chemoattractants.
Neutrophils rolling on P-selectin borne by endothelial
cells can utilize IL-8 produced by endothelial cells to pro-
mote the conversion from rolling to stationary adhesion
to endothelial layer [9]. Once adherent to the endothe-
lium, granulocytes may in turn secrete reactive oxygen
species as well as proteolytic enzymes [10]. Expression of
IL-8 family members increases in ischemic tissues soon
after reperfusion in experimental models of renal [11, 12],
retinal [13], cardiac [14], and lung ischemia [6]. Finding
that the administration of a neutralizing anti-IL-8 mono-
clonal antibody prevented neutrophil infiltration and tis-
sue injury in a rabbit model of lung reperfusion injury
would indicate the pathophysiologic role of locally pro-
duced IL-8 [6].
The present study was performed in a rat model of
I/R renal injury after transplantation induced by pre-
exposure of the graft to cold storage solution [15] to eval-
uate the involvement of granulocyte recruitment via the
CXCR2 pathway in reperfusion injury of renal grafts. To
address this issue we evaluated (1) the time course of
renal infiltration of granulocytes together with CINC-1/
IL-8 expression early after reperfusion in syngeneic or
allogeneic strain combinations; and (2) the effect of the
treatment with a specific inhibitor (repertaxin) of CXCR2
on intragraft granulocyte infiltration as well as on renal
graft function.
Repertaxin inhibits in a dose-dependent manner hu-
man neutrophil chemotaxis induced by IL-8 in vitro [16].
Repertaxin also inhibits the chemotaxis of rat neutrophils
induced by CINC-1 [16, 17]. Mechanistic studies have
shown that repertaxin acts as a noncompetitive allosteric
inhibitor, blocking the intracellular signal transduction
that follows engagement of IL-8 or CINC-1 with corre-
sponding receptors present on neutrophil surface [16, 17].
Different doses of repertaxin and several times of drug
administration were tested to find the most effective reg-
imen in preventing granulocyte infiltration and renal im-
pairment in our experimental model.
METHODS
Animals
Inbred adult male Lewis rats (RT1l) (Charles River,
Calco, Italy) were used as donor and recipients, respec-
tively, in syngeneic kidney transplants. Brown Norway
rats were used as recipient and Lewis as donor in allo-
geneic transplants.
Animal care and treatment were conducted in accor-
dance with institutional guidelines in compliance with
national (D.L. n.116, G.U. Suppl. 40, February 18, 1992,
Circolare n.8, G.U. July 14 1994) and international laws
and policies (European Economic Community Council
Directive 86/609, OJL 358, December 1987; “Guide for
the Care and Use of Laboratory Animals,” U.S. National
Research Council, 1996). All animals were allowed free
access to standard rat chow and tap water.
Experimental design
We first assessed the kinetics of CINC-1/IL-8 expres-
sion and granulocyte accumulation in the kidney after
syngeneic or allogeneic transplantation (Fig. 1A). Either
for syngeneic and allogeneic combinations, all the ani-
mals underwent a graft biopsy 1 hour after transplanta-
tion (N = 6); thereafter, rats were divided in two groups
and sacrificed 3 hours after transplantation (N = 3) or 24
hours after transplantation (N = 3). Renal tissues were
processed for CINC-1/IL-8 mRNA analysis and quantifi-
cation of granulocyte infiltration. As control, Lewis kid-
neys exposed to cold ischemia but not grafted were used
(N = 3).
To assess whether CXCR2 inhibition may prevent
granulocyte infiltration and preserve renal function, dif-
ferent doses of a specific CXCR2 inhibitor, repertaxin,
were tested in the syngeneic kidney transplantation
model (Fig. 1B). Repertaxin (R(-)-2-(4-isobutylphenyl)
propionyl methansulfonamide) salified with L-lysine was
dissolved in saline. The recipient animals received a sub-
cutaneous injection of repertaxin 24 hours before trans-
plantation, an intravenous administration immediately
before reperfusion of the transplanted kidney and a sub-
cutaneous injection 2 hours after transplantation. Ani-
mals were divided in four groups: group 1 receiving 5 mg/
kg repertaxin (N = 5), group 2 receiving 15 mg/kg reper-
taxin (N = 6), group 3 receiving 30 mg/kg repertaxin
(N = 3) and group 4 receiving vehicle (saline) (N = 8) at
the same time and route of administration of repertaxin.
The doses of repertaxin were found effective in rat models
of hepatic [16] and intestinal I/R injury [17]. Serum crea-
tinine concentrations were evaluated at 16 and 24 hours.
Animals were sacrificed at 24 hours after transplanta-
tion. At sacrifice kidneys were removed and processed
for immunohistochemistry assessment of infiltrated gran-
ulocytes.
We further evaluated whether shortening the pretreat-
ment time still protected the kidney after syngeneic trans-
plantation (Fig. 1C). To this purpose, two groups of Lewis
rats received a subcutaneous injection of 15 mg/kg of
repertaxin 2 hours (N = 8) or 8 hours (N = 4) before
transplantation, an intravenous administration immedi-
ately before reperfusion of the transplanted kidney and
a subcutaneous injection 2 hours after transplantation.
Serum creatinine was measured at 16 and 24 hours, time
at which the animals were sacrificed. At sacrifice kidneys
were removed and processed for immunohistochemistry
assessment of infiltrated granulocytes.
Once established, the dose and the treatment sched-
ule, the efficacy of repertaxin was tested after I/R injury
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Fig. 1. Experimental design. (A) To assess the kinetics of CINC-1/interleukin-8 (IL-8) expression and intragraft granulocyte infiltration following
ischemia/reperfusion (I/R) injury in syngeneic and allogeneic transplantation, rats recipients of syngeneic or allogeneic kidneys underwent a graft
biopsy 1 hour after transplantation; theareafter, kidneys were taken at sacrifice 3 or 24 hours after transplantation. (B) Different doses of repertaxin
were given to recipents rats to assess the effect of CXCR2 inhibition on granulocyte infiltration and renal function in syngeneic transplantation
model. (C) Syngeneic recipent rats were given repertaxin at different pretreatment time before transplantation. (D) repertaxin was given to Brown
Norway rats receiving a Lewis allogeneic kidney. Closed arrows are renal tissue taken for analysis; open arrows are measurement of serum creatinine
levels.
in the allogeneic kidney transplantation model (Fig. 1D).
We evaluated the effect of 15 mg/kg repertaxin given to
Brown Norway rats as a subcutaneous injection 8 hours
before transplantation, followed by an intravenous ad-
ministration immediately before reperfusion and a subcu-
taneous injection 2 hours after transplantation (N = 10).
As controls, Brown Norway rats receiving Lewis kidney
were given vehicle (N = 13). Serum creatinine was mea-
sured at 16 and 24 hours, time at which animals were sac-
rificed. At sacrifice kidneys were removed and processed
for immunohistochemistry assessment of infiltrated gran-
ulocytes.
Kidney transplantation
Kidney transplantation was performed as described
previously [18]. Donor animals were anesthetized with
Leptofen (Pharmacia, Uppsala, Sweden). The left kid-
ney was prepared by freeing the ureter from the attach-
ments. The renal artery was separated from the renal
vein by blunt dissection. The donor kidney and ureter
were removed en bloc and flushed with Belzer [Univer-
sity of Wisconsin (UW)] containing 1000 U/mL heparin.
Then the kidney was placed in an iced Belzer (UW) so-
lution for 4 hours (cold ischemia) until transplant. After
ischemia time elapsed, recipient rats underwent removal
of the native left kidney. Donor kidneys grafts were then
washed with saline solution and transplanted. An anasto-
mosis was created between the donor and recipient renal
artery as well as renal vein with end-to-end anastomosis.
Vascular clamps were released after 30 minutes (warm is-
chemia). Donor and recipient ureters were attached end-
to-end. The native right kidney was then removed.
Real-time quantitative polymerase chain reaction (PCR)
Total RNA was extracted from homogenated whole
kidneys or biopsies in the presence of TRIzol reagent (In-
vitrogen, Carlsbad, CA, USA). DNase-treated RNA was
primed with random hexamers and reverse transcribed
to cDNA using Superscript II Reverse Transcriptase
(Invitrogen).
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Quantitative real-time PCR was performed on a
TaqMan ABI Prism 5700 Sequence Detection System
(Applied Biosystems, Foster City, CA, USA) with SYBR
Green PCR Core reagents. To amplify rat CINC-1/IL-
8 transcripts the following primers were used, based on
Genbank sequence M86536.1, for (300 nmol/L) 5′-AAG
ATT GTC CAA AAG ATG CTA AAG G-3′ and re-
verse (300 nmol/L) 5′-ATC GGT GCA ATC TAT CTT
CTT TCT C-3′. Genomic DNA was not amplified since
primers spanned an exon junction. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) served as a house-
keeping gene to assess the overall cDNA content.
GAPDH primers were as follows: for (300 nmol/L)
5′-TCATCCCTGCATCCACTGGT-3′ and reverse (300
nmol/L) 5′-CTGGGATGACCTTGCCCAC-3′.
After an initial holding step of 2 minutes at 50◦C and
10 minutes at 95◦C, samples were cycled 40 times at 95◦C
for 15 seconds and 60◦C for 60 seconds. All reactions
were performed in triplicate. Similar amplification effi-
ciencies were demonstrated for both the target and the
housekeeping genes by analyzing serial cDNA dilutions,
showing an absolute value of the slope of log input cDNA
amount versus  threshold cycle (Ct) (Ct target Ct house-
keeping gene) of <0.1. Thus, the Ct equation was used
to compare the CINC-1/IL-8 expression in each sample
with the expression in a control kidney taken as reference
(calibrator).
Immunohistochemical analysis
The degree of granulocyte infiltration in glomerular
and interstitial areas was determined by indirect im-
munofluorescence. A mouse antirat granulocyte mon-
oclonal antibody (clone MOM/3F12/F2) (dilution 1:10)
(Valter Occhiena, Torino, Italy) was used to stain infiltrat-
ing granulocytes. Tissue fragments were frozen in liquid
nitrogen. Sections (3 lm thick) were cut using a Mikrom
500 O cryostat (Walldorf, Germany) and fixed in acetone.
Tissue sections were blocked with phosphate-buffered
saline (PBS)/1% bovine serum albumin (BSA), incu-
bated overnight at 4◦C with the primary antibody, washed
with PBS, and then incubated with cyanate-3 (Cy3)-
conjugated donkey antimouse IgG antibody (affinity-
purified, absorbed with rat IgG) (5 lg/mL in PBS)
(Jackson ImmunoResearch, West Grove, PA, USA) for
1 hour at room temperature. The number of cells was
counted in at least 20 glomeruli and 10 randomly selected
high-power microscope field (×400) taking interstitial ar-
eas of each animals.
Statistical analysis
Differences between groups were analyzed by one-way
analysis of variance (ANOVA) or Kruskal-Wallis as ap-
propriate. A P value of <0.05 was considered significant
(two-tailed analysis). Results are reported as mean ± SE.
RESULTS
Kinetics of CINC-1/IL-8 expression and intragraft
granulocyte infiltration following I/R injury of syngeneic
and allogeneic transplantation
The kinetics of CINC-1/IL-8 expression was analyzed
in kidneys pre-exposed to 4 hours of cold ischemia and
subsequently grafted in a syngeneic or allogeneic rat
strain combination. Real-time quantitative PCR on re-
verse transcribed RNA showed that CINC-1/IL-8 expres-
sion increased in both syngeneic and allogeneic groups
as compared to the levels observed in control kidneys.
The time course of CINC-1/IL-8 expression was simi-
lar in both groups reaching a peak at 3 hours after I/R
(Fig. 2A). At this time point the CINC-1/IL-8 transcript
levels in syngeneic and allogeneic groups were signifi-
cantly higher than those in control kidneys (P < 0.01
and P < 0.05, respectively). CINC-1/IL-8 expression was
higher in syngeneic than in allogeneic combination at
each time point analyzed, a trend that has already been
reported in a model of acute heart allograft rejection in
mice [14].
Granulocyte infiltration after I/R injury was also eval-
uated in the same animals. Figure 2B summarizes the
results of quantitative evaluation of granulocyte infiltra-
tion. A significant increase (P < 0.05) of the number
of granulocytes was already observed 1 hour after I/R
in intraglomerular and interstitial areas of the syngeneic
group in respect to controls. The granulocyte infiltration
remained stable at 3 hours and then slightly decreased
at 24 hours, remaining significantly higher than that ob-
served in the control group, however (P < 0.05). In the
allogeneic group granulocyte infiltration both in intra-
glomerular and interstitial areas rose rapidly following
I/R injury and remained significantly higher than that in
control group at all time points analyzed (P < 0.05 at
all time points in intraglomerular and interstitial areas).
These results show that in the experimental model of I/R
renal injury the significant increase of CINC-1/IL-8 levels
is associated with a marked infiltration of granulocytes in
renal tissue both in syngeneic and allogeneic transplan-
tation.
Effect of different doses of repertaxin on intragraft
granulocyte infiltration and renal function in syngeneic
transplantation
Recipient animals received three administrations of
the CXCR2 inhibitor repertaxin as follows: a subcuta-
neous injection 24 hours before transplantation, an intra-
venous administration immediately before reperfusion
of the transplanted kidney, and a subcutaneous injection
2 hours after transplantation. The effect of different doses
of repertaxin (5, 15, and 30 mg/kg, respectively) on gran-
ulocyte infiltration was determined 24 hours after syn-
geneic kidney transplantation (Fig. 3A). Treatment with
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Fig. 2. Kinetics of CINC-1/interleukin-8 (IL-8) mRNA expression and granulocyte infiltration after renal ischemia/reperfusion (I/R). Syngeneic
and allogeneic renal tissues were analyzed at different time points [1 hour (N = 6); 3 hours (N = 3); and 24 hours (N = 3)] after transplantation.
(A) cDNA from kidneys were analyzed by real-time polymerase chain reaction (PCR) to quantify CINC-1/IL-8 mRNA expression. The expression
level in the calibrator (control kidney, zero hour) is set to 1 (arbitrary unit). (B) Number of granulocytes counted in intraglomerular (left) and in
interstitial (right) areas in at least 10 randomly selected high-power macroscopic fields (HPF). Data are mean ± SE. #P < 0.01 vs. control kidney;
∗P < 0.05 vs. control kidney; †P < 0.05 vs. 1 hour; and §P < 0.05 vs. 3 hours.
repertaxin at the dose of 15 mg/kg significantly (P < 0.05)
decreased granulocyte infiltration in intraglomerular and
interstitial areas in respect to that observed in vehicle
group. Granulocyte counts in animals receiving 5 and 30
mg/kg were fairly comparable to that of vehicle-treated
animals.
Serum creatinine concentration was evaluated at 16
and 24 hours after syngeneic kidney transplantation
(Fig. 3B). At 16 hours, serum creatinine concentration
increase was significantly prevented by repertaxin at the
dose of 15 mg/kg (P < 0.001). Animals given the dose of
30 mg/kg showed creatinine levels comparable to those
measured in vehicle-treated animals. Of note, severe in-
flammation at the site of injection and hematuria was
observed in animals given this dose, which might account
for lack of effect of repertaxin on granulocyte infiltration
and graft function. Twenty-four hours after transplanta-
tion, serum creatinine concentration increase was pre-
vented by repertaxin at all the doses tested although to
a different extent. The dose of 15 mg/kg gave the best
protection on renal function impairment (P < 0.001 vs.
vehicle); a lower but significant effect was also observed
with 30 mg/kg (P < 0.05 vs. vehicle).
Overall, these data suggest that the most effective dose
in preventing granulocyte infiltration and renal function
impairment is 15 mg/kg.
Comparison of different pretreatment time of repertaxin
on intragraft granulocyte infiltration and renal function
in syngeneic transplantation
We then assessed whether shortening the pretreatment
period with repertaxin could still result in prevention of
granulocyte infiltration and renoprotection. Figure 4A
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Fig. 4. Effect of different administration
times of repertaxin 15mg/kg (−2, 0,+2 hours)
(N = 8); (−8, 0, +2 hours) (N = 4); or vehi-
cle (N = 13) on intragraft granulocyte infil-
tration and serum creatinine concentrations
in syngeneic transplantation. (A) Number of
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summarizes the results of quantitative evaluation of gran-
ulocyte infiltration in the graft at sacrifice. Values of
intraglomerular granulocyte accumulation were slightly
affected by repertaxin given either at −2 hours or at
−8 hours pretransplant. Eight hour pretreatment of the
recipient induced a significant reduction of the number of
granulocytes in interstitial area in respect to animals re-
ceiving vehicle (P < 0.05). A similar trend was observed
in interstitial area of grafts from animals treated 2 hours
before transplantation, although the difference in respect
to rats receiving vehicle did not reach statistical signifi-
cance.
Figure 4B shows the effect of repertaxin given 2 or
8 hours before transplantation on renal function. At
16 hours posttransplant, the serum creatinine levels were
reduced at a comparable extent in rats receiving the treat-
ment 2 and 8 hours before transplantation, in respect to
vehicle-treated animals (P < 0.001). However, 24 hours
after transplantation, animals with −8 hours pretreat-
ment had better preservation of renal function than rats
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receiving the compound 2 hours before transplantation
(P < 0.005 vs. P < 0.01).
Effect of repertaxin on intragraft granulocyte infiltration
and renal function in allogeneic transplantation
Once established that repertaxin effectively modulated
I/R injury in syngeneic kidney transplantation, we as-
sessed whether the treatment were of benefit in an exper-
imental model of allogeneic rat kidney transplant. Reper-
taxin at the dose of 15 mg/kg was administered to animals
with the same treatment regimen adopted for animals un-
dergone syngeneic transplantation. Figure 5A shows the
effect of repertaxin on the number of infiltrating gran-
ulocytes as detected by immunohistochemical staining.
Repertaxin administered to a recipient of an allogeneic
kidney significantly (P < 0.05) reduced the number of
granulocytes infiltrating the intraglomerular and the in-
terstitial areas of the kidney, as compared to that ob-
served in vehicle-treated rats.
Figure 5B shows the effect of repertaxin on serum crea-
tinine concentrations in rats 16 and 24 hours after receiv-
ing an allogeneic kidney transplant. A significant preven-
tion of the serum creatinine level increase was observed
both at 16 and 24 hours posttransplant in the groups
receiving the CXCR2 inhibitor starting 8 hours before
transplantation (P < 0.05 vs. vehicle group).
DISCUSSION
The main goal of this work was to gain insight into
the impact of blocking granulocyte recruitment via the
CXCR2 signaling in a model of renal posttransplant I/R
injury in the rat by using a novel inhibitor of CXCR2 in-
tracellular signal transduction, repertaxin L-lysine salt.
After 4 hours of cold ischemia followed by organ
transplantation, repertaxin administered to the recipient
animals was effective in preventing renal function impair-
ment both in syngeneic and in allogeneic settings. Con-
comitantly, the number of graft infiltrating granulocytes
was lowered by repertaxin in respect to vehicle-treated
rats, suggesting that the major therapeutic effect of the
inhibitor was to limit granulocyte infiltration, whose mas-
sive presence in the graft contributes to renal dysfunction
[19]. I/R injury is a pivotal pathogenetic mechanism in the
development of acute renal failure associated with re-
nal transplantation and appears to involve a complex in-
terplay between renal hemodynamcs, tubular injury, and
inflammatory processes. Activated neutrophils were im-
plicated as participating in the pathogenesis of I/R in-
jury through the generation of superoxide radicals and
inflammatory cytokines resulting in endothelial cell dam-
age and thereby renal blood flow decrease [20, 21]. As in
acute inflammation, neutrophils infiltrate down a concen-
tration gradient of chemotactic factor(s) after adherence
to endothelial cells through adhesion molecules. The sig-
1760 Cugini et al: Repertaxin prevents ischemia/reperfusion injury
nals mediating transendothelial leukocyte migration [22],
their recruitment and activation at the site of inflamma-
tion include.
Production of CXC chemokines such as IL-8, which is
induced, in turn, by reactive oxygen metabolites gener-
ated upon reperfusion [23, 24]. Beyond their chemotactic
activity on neutrophils, CXC chemokines may promote
the release of lysosomal enzymes and superoxide anions
by neutrophils, which concur to amplify the injury [10,
25]. In rodents the CXC chemokines CINC-1, MIP-2, and
CINC-2 are thought to be the rat counterpart of human
IL-8.
Here we first assessed the kinetics of CINC-1/IL-8
mRNA expression in the I/R transplanted kidney and
found it markedly up-regulated by reperfusion, rising
1 hour after revascularization to reach a peak within
3 hours, in contrast to the very low levels of the chemokine
in control kidneys only exposed to ischemia. Similar
changes in renal tissue levels of IL-8 have been already
reported in rats subjected to 60 minutes of renal is-
chemia. Renal levels of rat IL-8 evaluated by enzyme-
linked immunosorbent assay (ELISA) reached the peak
at 3 hours after reperfusion and decreased gradually
thereafter [12]. In addition, in a model of retinal I/R
injury produced by increasing intraocular pressure, the
expression of IL-8 mRNA in the rat retinal vessels was
induced with a comparable kinetics as for the kidney
[13]. In other studies, reperfusion of the ischemic my-
ocardium results in increased release of IL-8 in the rabbit
[26] and elevated plasma levels of the proinflammatory
chemokine were found in patients undergoing coronary
artery bypass surgery [27]. In the present study, analysis of
kidney RNA by real-time quantitative PCR indicated sig-
nificantly higher CINC-1/IL-8 transcript levels both in
isografts and allografts with respect to control kidneys.
However, the increase was more evident in isografts than
in allografts, in line with studies by Morita et al [14] in
murine cardiac graft. Concomitant with CINC-1/IL-8 up-
regulation, we observed as early as 1 hour after reperfu-
sion an increase of granulocyte counts in interstitial and
intraglomerular areas, which persisted along the exper-
iment. It is plausible that additional chemokines acting
through the CXCR2 receptor might contribute to gran-
ulocyte infiltration in kidney allografts, which might ex-
plain comparable numbers of granulocytes in isografts
and in allografts, in the face of lower CINC-1/IL-8 ex-
pression levels in the latter.
As repertaxin blocks the activity of CXCR1 (in human)
and CXCR2 receptors (in human and rat), it could po-
tentially inhibit the biologic activity of all the chemokines
acting through these molecules. Indeed previous in vitro
studies showed that repertaxin inhibits the intracellular
signal transduction induced by IL-8 in human polymor-
phonuclear cells and by CINC-1 and MIP-2 in rat poly-
morphonuclear cells [16, 17].
We found that repertaxin was capable to prevent graft
granulocyte infiltration and to limit serum creatinine in-
crease subsequent to I/R. Repertaxin allowed faster re-
covery of normal kidney function to the extent that
24 hours after transplantation serum creatinine levels
in repertaxin-treated rats tended to normalize, whereas
vehicle-treated animals still showed renal functional im-
pairment. Within the range of the doses tested, we found
that the effect of repertaxin was dose dependent: 5mg/kg
of repertaxin only partially prevented serum creatinine
increase, but had no effect on cellular infiltration. The
most effective dose of repertaxin was 15mg/kg, while the
local inflammation and hematuria induced with 30 mg/kg
could have negatively affected the response to repertaxin.
We administered the compound to recipient rats three
times starting at different time points before transplanta-
tion, to have an early block of CINC-1/IL-8 signaling in
recipient granulocytes. Granulocyte graft infiltration was
significantly reduced by repertaxin given 24 or 8 hours
before transplantation, while reduction with −2 hours
pretreatment was not significant, indicating that the du-
ration of pretreatment time is crucial to allow drug to
enter recipient polymorphonuclear cells and effectively
inhibit CINC-1/IL-8 biologic activity. From these results,
we suggest that the pretreatment at −8 hours followed by
injection immediately before reperfusion and 2 hours af-
ter transplantation with the dose of 15 mg/kg was the best
condition to prevent renal I/R injury. Furthermore, the
effectiveness of repertaxin in I/R injury after allogeneic
transplantation in preventing granulocyte graft infiltra-
tion and serum creatinine increase renders the present
results more relevant since this setting more closely mim-
ics the clinical condition.
Although leukocyte infiltration in response to I/R in-
jury is a well-known phenomenon, the contribution of
neutrophils to tissue damage is still controversial [28] to
the extent that some studies reported a beneficial effect
on graft function and tissue injury by preventing gran-
ulocyte accumulation [6, 29–34], whereas other studies
showed no effect [35, 36]. Our finding that repertaxin
blocks granulocyte infiltration and prevents serum cre-
atinine level increase strongly suggests a causal role of
granulocytes in renal function impairment by I/R in this
experimental model.
Overall our results show that blocking the CXCR2 sig-
naling by the use of repertaxin is effective in preventing
renal dysfunction due to I/R in syngenic and allogenic
transplantation.
Our finding is in line with very recent papers that re-
ported the effectiveness of repertaxin in preventing or-
gan damage in experimental models of rat hepatic [16]
and intestinal [17] I/R injury.
The efficacy of repertaxin to modulate I/R injury
opens new perspectives for preventing posttransplant
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delayed graft function, that negatively affects both short-
and long-term graft success of human transplantation.
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